greeksoup/ stock research
Stock research / United States / AZN / Year to 31 December 2022

AstraZeneca PLC (AZN) annual results, year to 31 December 2022: revenue USD 44,351 million, from the 20-F

AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2022 it reported revenue of USD 44,351 million, up 18.5% on the year before. Its profit attributable to shareholders was USD 3,288 million, up 2835.7%, and diluted earnings per share USD 2.11.

Revenue
USD 44,351 million
+18.5% on the year
FY2015FY2022
Operating margin
8.5%
2.8% a year earlier
FY2015FY2022
Net income
USD 3,288 million
+2,835.7% on the year
FY2015FY2022
Diluted EPS
USD 2.11
+2,537.5% on the year
FY2015FY2022

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2021Dec 2022
Revenue37,41744,351
Cost of sales12,43712,391
Gross profit24,98031,960
Research and development9,7369,762
Selling, general and administrative15,23418,419
Operating profit1,0563,757
Finance costs1,3001,346
Profit before tax-2652,501
Income tax-380-792
Profit for the year1153,293
Profit attributable to shareholders1123,288
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2021Dec 2022
Diluted EPS0.082.11
Basic EPS0.082.12
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2021Dec 2022
Cash from operations5,9639,808
Purchase of property, plant and equipment1,0911,091
Free cash flow4,8728,717
Cash from investing-11,058-2,960
Cash from financing3,649-6,823
Buybacks149n/a
Dividends paid3,8564,364
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2021Dec 2022
Funded by
Equity attributable to shareholders39,26837,037
Non-controlling interests19.021.0
Borrowings, as filed29,79428,279
Lease liabilities987953
Other liabilities35,29530,193
Total equity and liabilities105,36396,483
Owned
Property, plant and equipment9,1838,507
Goodwill19,99719,820
Other intangible assets42,49239,307
Cash and cash equivalents6,3296,166
Trade and other receivables9,64410,521
Inventories8,9834,699
Other assets8,7357,463
Total assets105,36396,483
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2021Dec 2022
Gross margin66.8%72.1%
Operating margin2.8%8.5%
Net margin0.3%7.4%
Free cash flow margin13.0%19.7%
Return on year-end equity0.3%8.9%
Effective tax raten/a-31.7%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2022, filed 18 February 2025: the filing. The figures are in US dollars as filed.